QPRC
Quest Patent Research Corporation0.1211
-0.2223-64.7%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
645.70KP/E (TTM)
-Basic EPS (TTM)
-0.78Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Quest Patent Research posted no revenue in Q3 FY2025 ended September 30, 2025, down from $900,000 y/y, driving a $1.0M operating loss versus $516K y/y while SG&A jumped 32% y/y to $1.0M on higher patent amortization from April's $9M Monterey buy (over 2,500 patents on data storage security, funded by QPRC Finance). Nine-month net loss hit $3.2M or $0.60/share (5.33M diluted shares), versus $1.5M or $0.28 y/y, with interest expense up on $17.8M funding liabilities to QPRC Finance/QF3 (non-recourse from IP monetization). Cash dipped to $175K after $1.5M operating burn; patents net $10.8M. Patents drive all cash flow. Litigation outcomes stay unpredictable.
10-Q
Q2 FY2025 results
Quest Patent Research posted no revenues in Q2 FY2025 ended June 30, 2025, down from $850k y/y, driving operating loss to $994k (vs $353k) and net loss $1.1M or $0.21/share (vs $447k or $0.08), reconciled to 5.33M diluted shares. SG&A jumped 21% y/y to $989k on $495k patent amortization after April's $9M Monterey buy (2,500+ patents on data storage security, funded by QPRC Finance non-recourse liability now $17.4M total with QF3). Cash fell to $255k amid $977k operating burn; funding liabilities dominate $22.1M current debt. Patents bulked to $11.4M net. Monetization delays sting.
10-Q
Q1 FY2025 results
Quest Patent Research posted no revenue in Q1 FY2025 ended March 31, 2025, down from $1,045,000 y/y in Q1 2024 from patent licensing settlements, swinging to a $657,802 operating loss from $93,831 while gross loss hit $3,496 versus $483,448 profit. Net loss widened to $826,385 ($0.15/share) from $431,442 ($0.08/share) on 5,331,973 diluted shares, with the gap to operating loss driven by $168,294 interest expense. Cash drained to $47,822 after $434,201 operating outflow; funding liabilities loom at $7.6M to QF3 and $2.8M related-party TMPO, both payable solely from IP monetization, plus $138,000 loans payable. Patents net $2.9M after $137,000 amortization. Cash burns fast. Post-quarter, tapped QPRC Finance for $9M Monterey patent buy (2,500+ assets on data storage/semiconductors) and $750,000 ops cash. Litigation sanctions risk eroding patents.
8-K
Secures $9M patent portfolio
Quest Patent Research entered a financing deal on April 11, 2025, with QPRC Finance, securing up to $19.5M for operations, patent buys, and enforcement. Subsidiary MR used $9M advance on April 18 to acquire Monterey's 2,500+ patents on data storage security and semiconductors. QPRC takes most monetization proceeds first; patents pledge collateral. Litigation fuels the bet.
IPO
Website
Employees
Sector
Industry
ACTG
Acacia Research Corporation
3.83+0.05
DGX
Quest Diagnostics Incorporated
178.66-5.45
LQWC
LifeQuest World Corp.
0.01-0.00
NTIP
Network-1 Technologies, Inc.
1.33-0.08
QRHC
Quest Resource Holding Corporat
2.20+0.14
QTZM
Quantumzyme Corp.
3.18+0.02
QWTR
Quest Water Global, Inc.
0.04+0.00
RMCO
Royalty Management Holding Corp
2.42+0.03
RPRX
Royalty Pharma plc
38.38-0.15
TRI
Thomson Reuters Corp
132.35+0.55